NCT02693119View on ClinicalTrials.gov

A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic Neuropathy

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

September 30, 2019

Study Completion Date

December 31, 2019

Conditions

Leber's Hereditary Optic Neuropathy

Interventions

DRUG

elamipretide (MTP-131) 1% topical ophthalmic solution

DRUG

Vehicle topical ophthalmic solution

Trial Locations (1)

91105

Doheny Eye Center, Pasadena

All Listed Sponsors

lead

Stealth BioTherapeutics Inc.

INDUSTRY

NCT02693119 - A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic Neuropathy | Biotech Hunter | Biotech Hunter